Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.

PubWeight™: 17.73‹?› | Rank: Top 0.1% | All-Time Top 10000

🔗 View Article (PMC 2684577)

Published in BMJ on May 19, 2009

Authors

M R Law1, J K Morris, N J Wald

Author Affiliations

1: Centre for Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, London EC1M 6BQ. m.r.law@qmul.ac.uk

Associated clinical trials:

Compare the Effects of Telemedicine Approach With Usual Care in Hypertension Management in China | NCT02919033

Home Blood Pressure Study for Recent Stroke Survivors With High Blood Pressure *On Hold Due to Global Pandemic* (HBPS) | NCT04226157

Mobile Technology for Blood Pressure Management | NCT04841317

Articles citing this

(truncated to the top 100)

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med (2010) 21.49

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet (2013) 7.34

Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet (2014) 4.11

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48

Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open (2014) 3.21

Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients. Eur Heart J (2012) 3.19

Medication adherence: WHO cares? Mayo Clin Proc (2011) 2.95

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol (2014) 2.88

Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol (2015) 2.78

CPAP versus oxygen in obstructive sleep apnea. N Engl J Med (2014) 2.75

Cost-effectiveness of hypertension therapy according to 2014 guidelines. N Engl J Med (2015) 2.47

Cost-effectiveness of community-based strategies for blood pressure control in a low-income developing country: findings from a cluster-randomized, factorial-controlled trial. Circulation (2011) 2.44

Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ (2011) 2.34

Sodium and potassium intakes among US adults: NHANES 2003-2008. Am J Clin Nutr (2012) 2.32

Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial. BMJ (2012) 2.23

Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. Int J Epidemiol (2012) 2.12

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J (2016) 2.09

Joint effect of mid- and late-life blood pressure on the brain: the AGES-Reykjavik study. Neurology (2014) 2.09

Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. Diabetes Care (2014) 2.05

Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke-Blood Pressure) randomised controlled trial. BMJ (2016) 2.05

Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open (2013) 1.95

The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One (2013) 1.95

Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension. Am J Hypertens (2010) 1.90

Using benefit-based tailored treatment to improve the use of antihypertensive medications. Circulation (2013) 1.89

Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens (2013) 1.86

Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: population-based study. Eur Heart J (2013) 1.79

Percutaneous renal denervation for the treatment of resistant essential hypertension; the first Dutch experience. Neth Heart J (2011) 1.68

Use of genetic markers and gene-diet interactions for interrogating population-level causal influences of diet on health. Genes Nutr (2010) 1.65

Randomized Polypill crossover trial in people aged 50 and over. PLoS One (2012) 1.64

School based education programme to reduce salt intake in children and their families (School-EduSalt): cluster randomised controlled trial. BMJ (2015) 1.62

Screening for future cardiovascular disease using age alone compared with multiple risk factors and age. PLoS One (2011) 1.56

The Health Equity and Effectiveness of Policy Options to Reduce Dietary Salt Intake in England: Policy Forecast. PLoS One (2015) 1.56

Declining 1-year case-fatality of stroke and increasing coverage of vascular risk management: population-based cohort study. J Neurol Neurosurg Psychiatry (2010) 1.51

Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trial. BMJ (2013) 1.49

Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control. Hypertension (2015) 1.48

Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis. Am J Hum Genet (2014) 1.45

Antihypertensive medication classes used among medicare beneficiaries initiating treatment in 2007-2010. PLoS One (2014) 1.45

Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ (2010) 1.43

Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus. Mayo Clin Proc (2011) 1.43

Updated national and international hypertension guidelines: a review of current recommendations. Drugs (2014) 1.41

Could NICE guidance on the choice of blood pressure lowering drugs be simplified? BMJ (2012) 1.41

Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial. BMC Med (2012) 1.40

Evidence for pharmacist care in the management of hypertension. Can Pharm J (Ott) (2015) 1.39

Can blood pressure be lowered safely in older adults with lacunar stroke? The Secondary Prevention of Small Subcortical Strokes study experience. J Am Geriatr Soc (2015) 1.38

Sex differences in primary hypertension. Biol Sex Differ (2012) 1.37

A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol (2013) 1.36

An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk. PLoS One (2011) 1.34

Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ (2016) 1.30

The relationship between preoperative and primary care blood pressure among veterans presenting from home for surgery: is there evidence for anesthesiologist-initiated blood pressure referral? Anesth Analg (2011) 1.27

Utility of electronic patient records in primary care for stroke secondary prevention trials. BMC Public Health (2011) 1.27

Sleep and hypertension. Chest (2010) 1.24

Potential impact of single-risk-factor versus total risk management for the prevention of cardiovascular events in Seychelles. Bull World Health Organ (2011) 1.23

Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clinicoecon Outcomes Res (2011) 1.22

Balancing harms and benefits of service mammography screening programs: a cohort study. Breast Cancer Res (2012) 1.19

The association of blood pressure and mortality differs by self-reported walking speed in older Latinos. J Gerontol A Biol Sci Med Sci (2012) 1.19

Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients. Eur Heart J (2013) 1.18

Blood pressure j-curve: current concepts. Curr Hypertens Rep (2012) 1.18

Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study. Hypertension (2014) 1.18

Digital health interventions for the prevention of cardiovascular disease: a systematic review and meta-analysis. Mayo Clin Proc (2015) 1.17

Patient and general practitioner attitudes to taking medication to prevent cardiovascular disease after receiving detailed information on risks and benefits of treatment: a qualitative study. BMC Fam Pract (2011) 1.16

Which interventions offer best value for money in primary prevention of cardiovascular disease? PLoS One (2012) 1.15

Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis. BMC Med (2012) 1.15

Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol (2010) 1.13

Cardiovascular risk management of hypertension and hypercholesterolaemia in the Netherlands: from unifactorial to multifactorial approach. Neth Heart J (2012) 1.13

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis. PLoS Med (2012) 1.12

Medical care and payment for diabetes in China: enormous threat and great opportunity. PLoS One (2012) 1.10

Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model. BMC Public Health (2010) 1.10

Effectiveness of interventions for hypertension care in the community--a meta-analysis of controlled studies in China. BMC Health Serv Res (2012) 1.09

Trends in population blood pressure and prevalence, awareness, treatment, and control of hypertension among middle-aged and older adults in a rural area of Northwest China from 1982 to 2010. PLoS One (2013) 1.06

Prevention of cardiovascular disease: why do we neglect the most potent intervention? Heart (2009) 1.05

Feedback GAP: study protocol for a cluster-randomized trial of goal setting and action plans to increase the effectiveness of audit and feedback interventions in primary care. Implement Sci (2010) 1.05

Coronary artery disease in Africa and the Middle East. Ther Clin Risk Manag (2012) 1.05

Causal relationship of susceptibility genes to ischemic stroke: comparison to ischemic heart disease and biochemical determinants. PLoS One (2010) 1.04

Utility of genetic determinants of lipids and cardiovascular events in assessing risk. Nat Rev Cardiol (2011) 1.04

Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. CMAJ (2014) 1.03

Improved cardiovascular risk prediction using nonparametric regression and electronic health record data. Med Care (2013) 1.02

A systematic review of recent clinical practice guidelines on the diagnosis, assessment and management of hypertension. PLoS One (2013) 1.01

More americans living longer with cardiovascular disease will increase costs while lowering quality of life. Health Aff (Millwood) (2013) 1.01

Lipids, blood pressure and kidney update 2015. Lipids Health Dis (2015) 1.00

Contributions of risk factors and medical care to cardiovascular mortality trends. Nat Rev Cardiol (2015) 1.00

The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled trials. PLoS One (2012) 1.00

Health screening for older people-what are the current recommendations? Malays Fam Physician (2015) 0.98

Does bilingualism influence cognitive aging? Ann Neurol (2014) 0.97

Mobile clinic in Massachusetts associated with cost savings from lowering blood pressure and emergency department use. Health Aff (Millwood) (2013) 0.97

Is yangxue qingnao granule combined with antihypertensive drugs, a new integrative medicine therapy, more effective than antihypertensive therapy alone in treating essential hypertension? Evid Based Complement Alternat Med (2013) 0.97

Achieved blood pressures in the secondary prevention of small subcortical strokes (SPS3) study: challenges and lessons learned. Am J Hypertens (2014) 0.97

Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study. Heart (2011) 0.96

Nebivolol: impact on cardiac and endothelial function and clinical utility. Vasc Health Risk Manag (2012) 0.96

Self-Screening and Non-Physician Screening for Hypertension in Communities: A Systematic Review. Am J Hypertens (2015) 0.96

Genetic predisposition to higher blood pressure increases coronary artery disease risk. Hypertension (2013) 0.95

Recommendations on screening for high blood pressure in Canadian adults. Can Fam Physician (2013) 0.95

Effects of Age and Functional Status on the Relationship of Systolic Blood Pressure With Mortality in Mid and Late Life: The ARIC Study. J Gerontol A Biol Sci Med Sci (2015) 0.94

Effect of collaborative care for depression on risk of cardiovascular events: data from the IMPACT randomized controlled trial. Psychosom Med (2013) 0.94

A review of the gastrointestinal therapeutic system (GITS) formulation and its effectiveness in the delivery of antihypertensive drug treatment (focus on nifedipine GITS). Integr Blood Press Control (2013) 0.94

Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial. Trials (2011) 0.93

Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study. JACC Cardiovasc Imaging (2014) 0.93

Health and economic impacts of eight different dietary salt reduction interventions. PLoS One (2015) 0.93

Cholesterol trials and mortality. Br J Clin Pharmacol (2016) 0.92

Articles cited by this

Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12

Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet (1990) 24.72

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet (2003) 12.67

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med (2008) 11.61

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ (2003) 11.21

Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation (2006) 10.05

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet (2000) 9.78

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet (2005) 9.00

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ (2003) 8.55

British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ (2004) 7.92

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA (2003) 7.42

Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med (2006) 6.83

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ (2008) 6.13

Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet (2001) 6.05

Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet (2000) 5.42

Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med (1995) 5.12

Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ (2006) 5.03

Atenolol in hypertension: is it a wise choice? Lancet (2004) 4.75

Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med (2009) 3.85

Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens (2003) 3.67

Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med (2005) 3.44

Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med (1994) 3.04

Beta-blockers for hypertension. Cochrane Database Syst Rev (2007) 2.91

Headaches and the treatment of blood pressure: results from a meta-analysis of 94 randomized placebo-controlled trials with 24,000 participants. Circulation (2005) 2.87

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens (2003) 2.71

Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention. Hypertension (2005) 2.54

Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health Technol Assess (2003) 2.44

Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation (1999) 2.39

Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2000) 2.37

Thiazide diuretics and the risk for hip fracture. Ann Intern Med (2003) 2.24

Angiotensin receptor blockers and myocardial infarction. BMJ (2004) 2.02

Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens (2007) 2.01

Beta-blockers and sudden cardiac death. Ann Intern Med (1995) 1.83

Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension. Clin Sci (Lond) (2002) 1.77

Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA (2003) 1.73

Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res (2005) 1.73

Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension (2001) 1.70

Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS) Hypertension (1997) 1.69

Thiazide-induced hypokalemia. Association with acute myocardial infarction and ventricular fibrillation. JAMA (1978) 1.68

Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ (2001) 1.57

The incidence of stroke after myocardial infarction: a meta-analysis. Am J Med (2006) 1.38

Blood pressure lowering for primary and secondary prevention of stroke. Hypertension (2006) 1.38

A prospective study of thiazide use and fractures in women. Osteoporos Int (1997) 1.35

How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. J Hypertens (2006) 1.28

The incidence of ischemic stroke in chronic heart failure: a meta-analysis. J Card Fail (2007) 1.23

Ventricular arrhythmias in patients with myocardial infarction and ischaemia. Relationship to serum potassium and magnesium. Drugs (1984) 1.19

Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study. Clin Nephrol (2005) 1.15

Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Obstet Gynecol (1992) 1.13

Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death. J Hypertens (1992) 1.12

Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation (1987) 1.12

Cardioselective beta-blockers for reversible airway disease. Cochrane Database Syst Rev (2002) 1.11

The pleiotropic effects of angiotensin receptor blockers. J Clin Hypertens (Greenwich) (2006) 1.11

The role of calcium antagonists in stroke prevention. J Clin Hypertens (Greenwich) (2005) 1.03

Calcium channel blockers and headache. Br J Clin Pharmacol (2006) 1.03

Hypokalemia as a cause of cardiac arrest: results of electrophysiologic testing and long-term follow-up. Am Heart J (1985) 1.00

Articles by these authors

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ (1994) 11.85

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ (2003) 11.21

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ (2003) 8.55

The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ (1997) 8.05

Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ (1997) 7.37

Increasing incidence of tuberculosis in England and Wales: a study of the likely causes. BMJ (1995) 6.44

Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol (1987) 6.20

Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. BMJ (1994) 6.05

Assessing possible hazards of reducing serum cholesterol. BMJ (1994) 5.61

Risk factor thresholds: their existence under scrutiny. BMJ (2002) 5.55

Quantifying the effect of folic acid. Lancet (2001) 4.86

Folic acid and the prevention of neural tube defects. BMJ (1995) 4.17

Factors that affect outcome of in-vitro fertilisation treatment. Lancet (1996) 4.13

Does breathing other people's tobacco smoke cause lung cancer? Br Med J (Clin Res Ed) (1986) 4.06

Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet (1984) 3.91

Strategies for prevention of osteoporosis and hip fracture. BMJ (1991) 3.78

Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med (2001) 3.55

Carbon monoxide in breath in relation to smoking and carboxyhaemoglobin levels. Thorax (1981) 3.49

By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction. BMJ (1991) 3.47

Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects. Lancet (1977) 3.31

Mortality from lung cancer and coronary heart-disease in relation to changes in smoking habits. Lancet (1976) 3.29

Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment. BMJ (1989) 3.27

Fetal loss in Down syndrome pregnancies. Prenat Diagn (1999) 3.15

Down's syndrome screening in UK. Lancet (1996) 3.11

Use of general practice by intravenous heroin users on a methadone programme. Br J Gen Pract (1992) 3.04

By how much does dietary salt reduction lower blood pressure? II--Analysis of observational data within populations. BMJ (1991) 3.01

Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer. BMJ (1995) 2.80

Why is mortality higher in poorer areas and in more northern areas of England and Wales? J Epidemiol Community Health (1998) 2.78

Urinary cotinine as marker of breathing other people's tobacco smoke. Lancet (1984) 2.74

By how much does dietary salt reduction lower blood pressure? I--Analysis of observational data among populations. BMJ (1991) 2.72

Inhaling habits among smokers of different types of cigarette. Thorax (1980) 2.50

Amniotic-fluid acetylcholinesterase as a possible diagnostic test for neural-tube defects in early pregnancy. Lancet (1979) 2.42

Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol (1988) 2.40

Reducing the risk of multiple births by transfer of two embryos after in vitro fertilization. N Engl J Med (1998) 2.39

Neonatal screening for cystic fibrosis. BMJ (1998) 2.26

Folic acid fortification and cancer risk. Lancet (2007) 2.17

Antenatal screening in Oxford for fetal neural tube defects. Br J Obstet Gynaecol (1979) 2.06

Cotinine-assisted intervention in pregnancy to reduce smoking and low birthweight delivery. Br J Obstet Gynaecol (1991) 1.96

Recent advances in screening for neural tube defects and Down's syndrome. Baillieres Clin Obstet Gynaecol (1987) 1.93

Alpha fetoprotein in the antenatal diagnosis of open neural tube defects. Br J Hosp Med (1980) 1.79

An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990. Eur J Clin Nutr (1994) 1.74

Death from ischaemic heart disease. Br Med J (1977) 1.70

Down's syndrome screening in the UK in 1998. Lancet (1999) 1.70

Comparison of models of maternal age-specific risk for Down syndrome live births. Prenat Diagn (2003) 1.65

Plasma retinol, beta-carotene and vitamin E levels in relation to the future risk of breast cancer. Br J Cancer (1984) 1.64

UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax (2011) 1.62

Couple screening for cystic fibrosis. Lancet (1993) 1.60

Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn (1995) 1.60

How should urinary cotinine concentrations be adjusted for urinary creatinine concentration? Clin Chim Acta (1990) 1.57

Neural-tube defects and vitamins: the need for a randomized clinical trial. Br J Obstet Gynaecol (1984) 1.56

Prenatal diagnosis of spina bifida and anencephaly by maternal serum-alpha-fetoprotein measurement. A controlled study. Lancet (1974) 1.55

Serum vitamin E and subsequent risk of cancer. Br J Cancer (1987) 1.54

Dietary salt and blood pressure. J Hypertens Suppl (1991) 1.54

Quantifying the decline in the birth prevalence of neural tube defects in England and Wales. J Med Screen (1999) 1.51

Down's syndrome: screening and antenatal diagnosis regionally in England and Wales 1989-2008. J Med Screen (2010) 1.51

Assessment of the value of reporting partial screening results in prenatal screening for Down syndrome. Prenat Diagn (2001) 1.45

Antenatal screening for Down's syndrome. Health Technol Assess (1998) 1.45

Measurement of activity of urea resistant neutrophil alkaline phosphatase as an antenatal screening test for Down's syndrome. BMJ (1990) 1.45

Journal of medical screening. J Med Screen (1994) 1.45

Trends in individual consumption of dietary fat in the United States, 1920-1984. Am J Clin Nutr (1990) 1.44

Down's syndrome screening with nuchal translucency. Lancet (1997) 1.44

What is genetic screening anyway? J Med Screen (1996) 1.41

Screening for neuroblastoma in children. J Med Screen (2002) 1.40

A randomized double-blind crossover trial to investigate the efficacy of screening for adult hypothyroidism. J Med Screen (2010) 1.39

A new approach to antenatal screening for Fragile X syndrome. Prenat Diagn (2003) 1.39

Relation of urinary cotinine concentrations to cigarette smoking and to exposure to other people's smoke. Thorax (1990) 1.38

Mortality in relation to tar yield of cigarettes: a prospective study of four cohorts. BMJ (1995) 1.37

Maternal serum alpha-fetoprotein and birth weight in twin pregnancies. Br J Obstet Gynaecol (1978) 1.35

Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ (1997) 1.34

By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease? Eur J Clin Nutr (1998) 1.34

Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice. Proc Natl Acad Sci U S A (2000) 1.33

Ovarian cell differentiation: a cascade of multiple hormones, cellular signals, and regulated genes. Recent Prog Horm Res (1995) 1.32

Cigarette consumption and serum cotinine in relation to birthweight. Br J Obstet Gynaecol (1987) 1.32

Relative intakes of tar, nicotine, and carbon monoxide from cigarettes of different yields. Thorax (1984) 1.25

Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors. J Med Chem (1996) 1.24

Folic acid and miscarriage: an unjustified link. Am J Med Genet (2001) 1.22

A case-control study of dietary carotene in men with lung cancer and in men with other epithelial cancers. Nutr Cancer (1991) 1.21

Is cascade testing a sensible method of screening a population for autosomal recessive disorders? Am J Med Genet A (2004) 1.21

Serum cotinine levels in pipe smokers: evidence against nicotine as cause of coronary heart disease. Lancet (1981) 1.17

Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies. Br J Cancer (2006) 1.14

The performance of blood pressure and other cardiovascular risk factors as screening tests for ischaemic heart disease and stroke. J Med Screen (2004) 1.13

Should testicular self examination be recommended? J Med Screen (1996) 1.13

Consultation rates among middle aged men in general practice over three years. BMJ (1990) 1.11

Congenital talipes and hip malformation in relation to amniocentesis: a case-control study. Lancet (1983) 1.10

Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study. BMJ (2000) 1.09

Maternal age-specific risk of non-chromosomal anomalies. BJOG (2009) 1.08

Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones. J Med Chem (1997) 1.06

Ascertainment and accuracy of Down syndrome cases reported in congenital anomaly registers in England and Wales. Arch Dis Child Fetal Neonatal Ed (2008) 1.04

Graphical presentation of distributions of risk in screening. J Med Screen (2005) 1.04

Calcium channel blockers and headache. Br J Clin Pharmacol (2006) 1.03

Can the coverage of screening for cancer of the cervix be improved using the Electoral Register? A pilot study. Cancer Lett (1985) 1.02

The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer. Br J Cancer (1997) 1.02

Screening for Down's syndrome using serum alpha fetoprotein. Br Med J (Clin Res Ed) (1985) 1.01